Adaptimmune Therapeutics (ADAP)
NASDAQ: ADAP
· Real-Time Price · USD
0.28
-0.00 (-1.06%)
At close: Jun 09, 2025, 3:58 PM
Adaptimmune Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 179.64M | 178.03M | 175.04M | 141.46M | 18.36M | 60.28M | 71.08M | 70.77M | 71.17M | 27.15M | 17.54M | 11.73M | 9.29M | 6.15M | 6.23M | 6.22M | 3.63M |
Cost of Revenue | 3.48M | 5.43M | 8.3M | 11.18M | 10.82M | 9.85M | 30.03M | 60.33M | 92.84M | 127.73M | 134.18M | 129.21M | 123.34M | 111.09M | 107.36M | 103.22M | 94.81M |
Gross Profit | 176.16M | 172.6M | 166.74M | 130.28M | 7.54M | 50.43M | 41.05M | 10.43M | -21.66M | -100.58M | -116.64M | -117.47M | -114.05M | -104.94M | -101.13M | -96.99M | -91.18M |
Operating Income | -65.23M | -68.76M | -49.26M | -80.87M | -194.47M | -143.56M | -116.78M | -113.48M | -112.33M | -163.97M | -179.59M | -178.78M | -174.34M | -162.25M | -156.9M | -150.59M | -141.53M |
Interest Income | 6.16M | 6.6M | 6.43M | 6.48M | 6.65M | 5.98M | 4.89M | 3.07M | 1.88M | 1.54M | 1.2M | 1.1M | 1.01M | 1.09M | 1.45M | 3.38M | 4.26M |
Pretax Income | -68.57M | -69.54M | -49.74M | -77.87M | -166.32M | -116.69M | -92.22M | -88.33M | -111.67M | -162.96M | -173.35M | -174.52M | -169.47M | -157.3M | -155.21M | -148.44M | -139.3M |
Net Income | -69.89M | -70.81M | -44.93M | -72.92M | -163.83M | -114.29M | -95.2M | -91.02M | -114.16M | -165.46M | -175.06M | -176.04M | -170.59M | -158.09M | -155.84M | -148.88M | -139.69M |
Selling & General & Admin | 82.14M | 78.59M | 71.52M | 66.41M | 70.12M | 70.79M | 71.85M | 72.5M | 69.32M | 65.73M | 65.29M | 63.65M | 61.74M | 58.76M | 57.22M | 55.05M | 50.35M |
Research & Development | 142.71M | 149.06M | 147.18M | 150.67M | 140.19M | 130.53M | 116.35M | 111.75M | 116.52M | 127.73M | 134.18M | 129.21M | 123.34M | 111.09M | 107.36M | 103.22M | 94.81M |
Other Expenses | 16.42M | 16.36M | -374K | -698K | -197K | -807K | -2.03M | -63K | -1.22M | -536K | 5.04M | 3.16M | 3.87M | 3.85M | 230K | -1.22M | -1.84M |
Operating Expenses | 243.99M | 246.79M | 221.43M | 219.8M | 210.31M | 201.31M | 188.21M | 184.25M | 183.5M | 191.11M | 197.12M | 190.51M | 183.63M | 168.4M | 163.13M | 156.81M | 145.16M |
Interest Expense | 5.23M | 3.35M | 1.64M | 531K | 5K | 5K | 1.01M | 1.34M | 1.34M | 1.68M | 841K | 742K | 1.01M | 1.09M | 916K | 2.84M | 3.72M |
Selling & Marketing Expenses | -2.22M | -2.22M | -5.45M | -5.45M | -2.73M | -2.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 242.55M | 244.47M | 224.3M | 222.67M | 213.18M | 204.19M | 188.21M | 184.25M | 183.5M | 191.11M | 197.12M | 190.51M | 183.63M | 168.4M | 163.13M | 156.81M | 145.16M |
Income Tax Expense | 92.92K | 141.92K | -5.94M | -7.46M | -4.92M | -3.77M | 1.61M | 2.7M | 2.49M | 2.5M | 1.71M | 1.52M | 1.13M | 792K | 634K | 441K | 390K |
Shares Outstanding (Basic) | 257.03M | 255.94M | 255.77M | 255.59M | 241.87M | 227.11M | 226.31M | 184.69M | 165.22M | 164.12M | 163.47M | 160.47M | 156.67M | 156.22M | 156.1M | 155.7M | 155.18M |
Shares Outstanding (Diluted) | 257.03M | 255.94M | 255.77M | 259.86M | 241.87M | 227.11M | 226.31M | 184.69M | 166.71M | 164.12M | 163.47M | 160.47M | 156.67M | 156.22M | 156.1M | 155.7M | 155.18M |
EPS (Basic) | -0.27 | -0.29 | -0.21 | -0.34 | -0.72 | -0.52 | -0.49 | -0.54 | -0.72 | -1.02 | -1.08 | -1.14 | -1.08 | -1.02 | -1.02 | -0.96 | -0.9 |
EPS (Diluted) | -0.27 | -0.29 | -0.21 | -0.34 | -0.72 | -0.52 | -0.49 | -0.54 | -0.72 | -1.02 | -1.08 | -1.14 | -1.08 | -1.02 | -1.02 | -0.96 | -0.9 |
EBITDA | -52.48M | -56.25M | -38.12M | -69.01M | -160.99M | -116.42M | -90.08M | -87.84M | -109.07M | -155.59M | -174.95M | -174.18M | -169.85M | -157.91M | -155.99M | -149.57M | -140.09M |
EBIT | -65.65M | -69.78M | -46.52M | -77.48M | -166.46M | -120.92M | -96.01M | -92.36M | -115.41M | -161.67M | -179.59M | -178.78M | -174.34M | -162.25M | -156.9M | -150.59M | -141.53M |
Depreciation & Amortization | 10.84M | 11.2M | 11.27M | 11.32M | 10.82M | 9.85M | 8.42M | 7.03M | 6.33M | 6.05M | 6.84M | 6.81M | 6.71M | 6.57M | 6.05M | 6.43M | 7.14M |